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Abstract
The YbeB (DUF143) family of uncharacterized proteins is encoded by almost all bacterial and eukaryotic genomes but not
archaea. While they have been shown to be associated with ribosomes, their molecular function remains unclear. Here we
show that YbeB is a ribosomal silencing factor (RsfA) in the stationary growth phase and during the transition from rich to
poor media. A knock-out of the rsfA gene shows two strong phenotypes: (i) the viability of the mutant cells are sharply
impaired during stationary phase (as shown by viability competition assays), and (ii) during transition from rich to poor
media the mutant cells adapt slowly and show a growth block of more than 10 hours (as shown by growth competition
assays). RsfA silences translation by binding to the L14 protein of the large ribosomal subunit and, as a consequence,
impairs subunit joining (as shown by molecular modeling, reporter gene analysis, in vitro translation assays, and sucrose
gradient analysis). This particular interaction is conserved in all species tested, including Escherichia coli, Treponema
pallidum, Streptococcus pneumoniae, Synechocystis PCC 6803, as well as human mitochondria and maize chloroplasts (as
demonstrated by yeast two-hybrid tests, pull-downs, and mutagenesis). RsfA is unrelated to the eukaryotic ribosomal anti-
association/60S-assembly factor eIF6, which also binds to L14, and is the first such factor in bacteria and organelles. RsfA
helps cells to adapt to slow-growth/stationary phase conditions by down-regulating protein synthesis, one of the most
energy-consuming processes in both bacterial and eukaryotic cells.
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Introduction
Escherichia coli harbors a core set of about 190 genes that are
conserved in more than 90% of all completely sequenced genomes
[1]. Most of them encode well-understood proteins involved in
metabolism, transcription, translation, or replication. However, a
few of these highly conserved proteins remain functionally
uncharacterized and thus enigmatic. One of these mysterious
proteins is YbeB. In 2004 it was proposed by Galperin and Koonin
as one of 10 top targets of conserved hypothetical proteins for
experimental characterization [2]. In recent interactome studies, we
and others found this protein to interact with various proteins,
including several ribosomal components [3,4,5,6]. Moreover, YbeB
was shown to co-sediment with the large ribosomal subunit (LRS)
[7], suggesting that it functions in protein translation. Recently it has
been suggested that its mitochondrial homologue, C7orf30, is
involved in ribosome biogenesis and/or translation [5,8] although
these studies were not able to explain their observations mechanis-
tically. In this work we characterize YbeB’s molecular function by
identifying its binding site on the LRS and reveal a molecular
mechanism of YbeB action: it is down-regulating protein synthesis
under nutrient shortage by binding to protein L14 of the LRS,
acting as a ribosomal silencing factor (‘‘RsfA’’) by blocking ribosome
subunit joining. Thus, we will use the term ‘‘RsfA’’ below.
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Results
RsfA homologues are conserved from bacteria to
humans and interact with the ribosomal protein L14
In the Pfam database (V26.0) RsfA sequence homologues are
known for at least 2,928 species, including nearly all bacteria as
well as almost all eukaryotic species (Pfam entry PF02410, Interpro
IPR004394). However, the RsfA protein family is conspicuously
absent in archaea (Figure 1A). In the STRING 9.0 database [9]
RsfA is clustered with the orthologous protein group ‘‘COG0799’’,
consisting of 932 RsfA homologues in 920 different species,
indicating that there is usually one rsfA gene per genome. A
multiple sequence alignment of ten representative RsfA ortholo-
gues, however, exhibits only limited conservation when compared
to ribosomal protein L14 (Figure S1).
Interestingly, more than 80% of all eukaryotic RsfA orthologues
are predicted to localize to mitochondria or chloroplasts according
to the WoLF PSort program [10]. For the yeast orthologue
ATP25, the mitochondrial localization has been experimentally
confirmed [11] and the Zea mays homologue, Iojap, was found in
chloroplast fractions [12]. This strongly suggests that RsfA
functions in a strictly conserved process of bacterial origin.
Previously, Butland and colleagues reported L14, L19, L4, L7/
L12 and others as interaction partners of RsfA based on protein
complex data [3]. Similarly, we found that several interactors of
RsfA’s Treponema pallidum orthologue TP0738 were involved in
protein synthesis [6]. Although these observations provided the
first experimental hint that RsfA might function in translation, this
has never been functionally demonstrated. Since previous studies
have revealed RsfA’s association with the large ribosomal subunit
(LRS) which offers multiple binding sites, we re-tested all
previously detected interactions of T. pallidum RsfA that are
involved in protein translation. As expected, several proteins
indeed tested positive (Figure 1B). However, the interaction of
RsfA with L14 was by far the strongest as determined by using
increasing concentrations of 3-amino-triazole (3-AT), a competi-
tive inhibitor of the yeast two-hybrid reporter gene HIS3. In fact,
only the interaction with L14 was detectable at more than 1 mM
3-AT. Furthermore, the L14-RsfA interaction was the only one
that was detectable in a reciprocal screen, i.e. with RsfA used as
both bait and prey.
Given the conservation of RsfA, we wanted to establish to which
extent the interactions of RsfA of T. pallidum are conserved in other
species. To this end, we first retested whether the interactions of T.
pallidum RsfA are conserved in E. coli. We also included eight
putative interaction partners that have been identified in a protein
complex together with E. coli RsfA and L14 [3] and four
interologous pairs detected by Y2H in Campylobacter jejuni [13].
Surprisingly, only the interaction with L14 was conserved in E. coli
as a strong (up to 50 mM 3-AT) and reciprocal interaction
(Figure 1C, all tested interactions and reference sets are listed in
Table S2 and the complete Y2H assays are shown in Figure S2).
Moreover, we confirm the interaction of RsfA with L14 from E.
coli independently in a pull-down experiment (Figure S3A).
Thus, we conclude that L14 is the primary and specific binding
target of RsfA on the LRS and that all other interactions are
species specific or even artifacts.
Next we tested whether this particular interaction is conserved
in other bacteria. Notably, we could verify the interaction in all
tested species, including gram-positive Streptococcus pneumoniae and
the cyanobacterium Synechocystis PCC 6803 (Figure S3B and S3C).
In addition, we confirmed the interaction between the corre-
sponding orthologues of RsfA/L14 of both human (C7orf30/
mitochondrial L14) and Zea mays (Iojap/chloroplastic RPL14) as
shown in Figure 1D and 1E, respectively.
In HeLa cells human C7orf30 co-localized with L14mt
exclusively to mitochondria (Figure 1F). This supports the
hypothesis that eukaryotic RsfA orthologues are functionally
active only in organelles. Finally, we verified the human protein
interaction in vivo by a bimolecular fluorescence complementation
assay using C-terminally tagged Split-Venus constructs (Figure 1G).
In summary, these results strongly suggest that the interaction of
RsfA and L14 is universally conserved in all species that encode
RsfA homologues and that in fact their specific binding site at the
LRS is in the ribosomal protein L14.
RsfA binds to critical residues of ribosomal protein L14 at
the ribosomal subunit interface
In order to map the exact binding site of RsfA we used the LRS
3D structure (PDB id: 2AWB [14]: first, we identified amino acids
of L14 that (i) are highly conserved (Figure 2A(a) and 2A(b)) and
that (ii) are located on the surface exposed towards the 30S small
subunit interface. These criteria identified T97, R98, K114, and
S117. (Figure 2A(b,c)). In fact, docking a homology model of RsfA
and a crystal structure of L14 predicted these residues to be at
their interaction interface (Figure 2B). In order to test whether the
identified residues of L14 are indeed essential for the L14-RsfA
interaction, we substituted T97, R98, K114, and S117 with a
single alanine each and tested these L14 constructs if they still
bound RsfA by another Y2H experiment (Figure 2C): the K114A
and T97A mutants lost the interaction with RsfA already in the
presence of 0 to 1 mM 3-AT, while in R98A the interaction was
lost at 10 mM and higher concentrations. S117A did not appear to
affect the interaction. Several control mutations including
moderately conserved amino acids (D80A, F100A, E121A) and
none-conserved ones (R49A, K51A) did not show any difference in
the Y2H assay compared to the assayed wild type L14 (Figure 2A,
2C).
In summary, the interaction epitope assay confirms that the
docking model (Figure 2B) is largely correct. The RsfA-interaction
epitope of L14 involves the highly conserved residues K114, T97,
and R98 (but not S117) while K114 and T97 are the most critical
ones. Notably, T97 and R98 are involved in bridge B8
(Figure 2A(d)) that contacts the small ribosomal subunit [15].
The docking model predicts that binding of RsfA to these residues,
as a consequence, would sterically interfere with ribosome subunit
joining (Figure 2B(b)) and thus might block translation.
Author Summary
The YbeB/DUF143 family of proteins is one of the most
widely conserved proteins with homologues present in
almost all bacteria and eukaryotic organelles such as
mitochondria and chloroplasts (but not archaea). While it
has been shown that these proteins associate with
ribosomes, their molecular function remained mysterious.
Here we show that a knock-out of the ybeB gene causes a
dramatic adaptation block during a shift from rich to poor
media and seriously deteriorates the viability during
stationary phase. YbeB of six different species binds to
ribosomal protein L14. This interaction blocks the associ-
ation of the two ribosomal subunits and, as a conse-
quence, translation. YbeB is thus renamed ‘‘RsfA’’ (ribo-
somal silencing factor A). RsfA inhibits translation when
nutrients are depleted (or when cells are in stationary
phase), which helps the cell to save energy and nutrients, a
critical function for all cells that are regularly struggling
with limited resources.
RsfA Is a Ribosomal Silencing Factor
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Figure 1. RsfA and L14 and their interaction are conserved in bacteria and eukaryotic organelles. (A) Phylogenetic distribution of RsfA
(Interpro entry IPR004394 [DUF143]) and ribosomal protein L14 (IPR000218) on the iTOL tree of life [59]. Triangles indicate species in which the RsfA-
L14 interaction was detected by binary detection assays (grey), co-purification with the LRS (white) or both (black). Known RsfA-L14/LRS interactions
are listed in Table S1. (B) T. pallidum RsfA (TP0738) interacts strongly with L14 (TP0199) and very weakly with other proteins involved in translation [6]
in yeast-two-hybrid assays. C, control (with empty prey vector to measure self-activation of the bait). This interaction is also conserved in E. coli (C). (D,
E) RsfA and L14 homologues from human and maize interact in pull down experiments. RsfA homologues were tagged with NusA-His6 (N) and L14
homologues with maltose binding protein (M) (human mtRsfA=C7orf30, mitochondrial ribosomal protein L14= L14mt; maize RsfA = Iojap, maize
chloroplastic L14 = RPL14); i = input samples, o = output samples. Constructs with the corresponding Interpro signatures and the range of cloned
codons are illustrated on the right. (F) Human mitochondrial C7orf30 (mtRsfA) co-localizes with L14mt exclusively into mitochondria as visualized by
MitoTracker Green. Nuclei visualized by DRAQ5 (blue) and membranes by eCFP-membrane (cyan). Co-localization of both mtRsfA (C7orf30) and L14mt
in mitochondria is indicated in yellow. (G) Bi-molecular fluorescence complementation (BiFC) reveals the interaction of mtRsfA (C7orf30) and L14mt in
mitochondria. Overlay images represent DRAQ5 (blue), CFP-membrane (cyan) and BiFC stained cells. Green fluorescence indicates interaction-
dependent regeneration of the Venus protein. Constructs are shown below. Here, the hexagons symbolize the native N-termini including
mitochondrial localization sequences.
doi:10.1371/journal.pgen.1002815.g001
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RsfA confers a strong selective advantage under natural
growth conditions
Although RsfA is phylogenetically highly conserved, its gene
deletion has been reported not to result in any obvious growth
disadvantage in E. coli [7,16]. We designed a sensitive growth
experiment, which compares the WT and the rsfA deletion strain
under competitive growth conditions: we mixed equal amounts of
both cell types and monitored the populations at constant time
intervals under log-phase conditions. Figure 3A demonstrates that
the amounts of mutant cells decreased continuously. In other
words, WT cells in rich medium steadily overgrew the mutant cells
leaving only about 10 to 25% of mutant cells after 35 generations.
This modest effect reveals that RsfA mutant cells suffer from a
disadvantage when competing with WT cells. Strikingly, a much
Figure 2. Mapping the RsfA binding site on ribosomal protein L14. (A) L14 in the context of the 3D structure of the 50S ribosomal subunit (a)
(PDB: 2AWB) [14]. (b) Conserved residues of L14: magenta (highly conserved), grey (moderately conserved), turquoise (little or no conservation). (c)
Mutated residues for interaction epitope mapping (red or green); residues involved in (red colors) and not involved (green colors) in RsfA-binding
based on results from subfigure (C). (d) Residues of L14 highlighted that are involved in formation of intersubunit bridges with the 16S rRNA of the
30S subunit (bridge B5 (green colors), bridge B8 (red colors)) [15]. (B) A docking model of L14 on the E. coli 50S subunit with bound RsfA. Critical L14
residues that mediate RsfA interaction (or that contact 16S rRNA) are colored in red according to A(c) and A(d). When RsfA is bound to L14 on a 50S
subunit, 30S subunit joining is sterically blocked, clearly visible in B(b) as shown by the structural overlap of RsfA (dark blue) and the 30S subunit. A
model of the ribosome with bound RsfA is available as Dataset S1. (C) L14 interaction epitope mapping. Amino acids (see Figure 2A(c)) were mutated
to alanine and the constructs tested by Y2H experiments. WT, wild type L14 construct; mutated residues and their positions are indicated. In the
experiment, all bait constructs were simultaneously tested for reporter gene self-activation. No construct resulted in self-activation (data not shown).
T97A, R98A, or K114A mutations (highlighted by arrows) abolished or weakened RsfA binding as indicated by 3-AT titrations; all other tested L14
mutation constructs are comparable to wild type L14.
doi:10.1371/journal.pgen.1002815.g002
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Figure 3. RsfA inhibits translation during both stationary phase and the transition from rich to poor media. (A) Growth competition
experiment: equal numbers of E. coli wild type and DrsfA cells derived from an overnight LB-culture were mixed and grown in rich medium (LB,
richRrich), poor medium (M9, richRpoor) and poor medium plus 2% casamino acids as indicated (richRpoor+aa). Growth was maintained in log
phase conditions by regular dilutions in the corresponding media. Shown is the fraction of viable DrsfA mutant cells in the total cell population. (B)
Wild type and mutant strains were grown overnight in rich medium (LB) and then diluted in rich (richRrich) or poor M9 medium (richRpoor). The
generation time was derived from the slopes of the regression lines made of the points indicating the logarithmic phase. The errors of the
generation-time determinations are below 65%, i.e. generation times of 30 and 32 min are not significantly different. (C) Wild type and mutant
strains transformed with a plasmid harboring the gene for RsfA fused with a His-tag under control of the native promoter or the corresponding
empty plasmid were grown overnight in rich medium (LB) and then diluted in poor M9 medium. At certain times samples were withdrawn (S1–S6)
and the relative amount of RsfA was quantified by Western-blot (represented with bars). S1–S3: samples were analyzed from both strains. S4–S6:
samples were analyzed only from wild type (blue) or mutant strain (red). (D) Same as (C) but using a plasmid with a His-tagged RsfA gene under a tac
promoter. After ,3 h incubation in M9 medium 0.2 mM IPTG (final concentration) was added to all strains in order to induce expression from the tac
promoter. (E) Viability competition similar to the growth competition described under (A) but in a batch culture without dilution. Red, growth of the
mixture of DrsfA and WT strains; blue, the fraction (in %) of the mutant strain. (F) Expression of b-galactosidase as reporter to test translational activity
of logarithmic and stationary phase cells in WT and DrsfA cells induced by 2% arabinose. Induction time was 3 h in logarithmic and 2.5 and 6.5 h in
stationary phase. The expression level was derived from the band-intensity on a gel (Coomassie-stained SDS-PAGE).
doi:10.1371/journal.pgen.1002815.g003
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stronger difference was observed, when cells grown in rich
medium were diluted in minimal medium: the WT strain
overgrew the mutant DrsfA strain within only five generations.
The opposite growth transition (poorRrich media) is better
tolerated by the mutant strain. The addition of amino acids to the
minimal medium completely rescues this striking growth defect of
the rsfA mutant in the richRpoor media transition (see Discussion).
These strong defects seen with the DrsfA strain in minimal
medium rather than in rich medium should be evident also in a
direct determination of the doubling times of wild type versus
mutant in separate cultures. In rich medium the generation
times of WT and mutant strains were not significantly different
(30 and 32 min, respectively; Figure 3B). However, a change
from rich to poor medium revealed a dramatic difference:
initially the DrsfA mutant strain showed a growth like the WT
strain for about 7 h, but then growth was abrogated for about
14 h before it resumes almost with the same doubling time as
the WT strain (130 versus 120 min). The growth block for many
hours demonstrates that the lack of the rsfA gene poses a serious
adaptation problem on the cells after a transition from rich to
poor medium.
It has been reported that the rsfA (formerly ybeB) knock-out can
cause a defect in cell separation in a distinct genetic background,
and this defect can be complemented with genes of the rsfA operon
downstream of the rsfA gene indicating a polarity effect of the rsfA
deletion [17]. Therefore, we tested whether we can complement
the strong mutant phenotype observed in Figure 3A and 3B by
introducing a plasmid carrying the rsfA gene. If so, it would prove
that the mutant phenotype is caused by the absence of the RsfA
factor. To this end, we removed the kanamycin cassette in place of
the chromosomal rsfA gene and introduced a plasmid with the rsfA
gene under the native promoter; the expressed RsfA carried a His-
tag at the C-terminus to monitor the expression by anti-His
antibodies. Figure 3C demonstrates that the mutant phenotype
could not be cured probably due to the fact that after the shift to
the poor medium RsfA was not sufficiently expressed, whereas
taking up growth after 30 h was accompanied by a strong RsfA
expression (see red bars in Figure 3C). Therefore, we performed
the same experiment but now with the rsfA gene under a tac
promoter. The forced RsfA expression could heal the mutant
phenotype (Figure 3D; red closed circles). We conclude that (i) the
RsfA expression is regulated in a way we do not yet understand,
and (ii) that the lack of RsfA is responsible for the mutant
phenotype.
Figure 3A and 3B demonstrate that mutant and WT strains
showed almost the same growth behavior under log-phase
conditions in rich medium (LB). But what happens in a batch
culture, when a mixture of both strains reaches the stationary
phase in rich medium and protein synthesis has to be down
regulated? This was tested in the next experiment. The stationary
phase is reached after about 7 h (red line in Figure 3E). At various
time points aliquots were taken and the fraction of DrsfA mutant
strains were determined (blue bars). Until reaching the stationary
phase the fraction of mutant cells remains constant at about 35%,
but thereafter the fraction of mutant cells sharply declined to less
than 10%. This viability competition assay indicates that the
mutant cells have serious problems to form stable stationary-phase
cells.
The experiments shown in Figure 3A–3E disclose two strong
phenotypes caused by the lack of RsfA: (i) The cells adapt poorly
after the transition from rich to poor media, and (ii) the viability of
cells is dramatically impaired during the stationary phase,
eventually causing cell death.
RsfA acts as a negative modulator of protein translation
in vivo
Given RsfA’s physical association with the large ribosomal
subunit/L14, we wondered whether RsfA has an effect on protein
synthesis. To this end we expressed b-galactosidase (as an L-
arabinose inducible reporter) in an E. coli gene deletion strain
(DrsfA) and wild type (WT) cells. At stationary phase the b-
galactosidase expression was strongly repressed in wild type cells as
expected (Figure 3F). In striking contrast, the DrsfA mutant
exhibited a significant accumulation of b-galactosidase in the
stationary phase. These results demonstrate that RsfA acts as a
negative modulator of protein translation in vivo in the stationary
phase. Together with the viability assay (Figure 3E) these results
suggest that silencing protein synthesis plays an important role for
reorganization of the metabolic conversion on the way to the
stationary phase.
RsfA is a ribosomal silencing factor that interferes with
the association of ribosomal subunits
Next we tested whether RsfA interferes with ribosomal
elongation in vitro using a highly resolved E. coli system just
containing purified elongation factors EF-Tu, EF-Ts, EF-G,
purified precharged [14C]Phe-tRNA, poly(U) programmed ribo-
somes and GTP as energy source. We added 30S subunits to an
excess of 50S subunits in order to facilitate association to 70S
ribosomes. Purified RsfA suppressed the translational activity
dramatically down to about 20%, when RsfA was added to the
50S subunits before the oligo(Phe) synthesis (Figure 4A, left panel).
To test whether RsfA blocks ribosomal activities via interfering
with association of the subunits as suggested by our protein
docking model (Figure 2B), we subjected an aliquot to a sucrose-
gradient analysis before incubating for oligo(Phe) synthesis
(Figure 4B). The gradients demonstrate that in the absence of
RsfA clearly more 70S ribosomes are formed on the cost of
ribosomal subunits. However, when RsfA was added to pro-
gramed 70S ribosomes carrying an AcPhe-tRNA at the ribosomal
P site, no inhibition was observed indicating that RsfA does not
interfere with ribosomal functions during the elongation phase
(Figure 4A, right panel). We conclude that RsfA blocks association
of the ribosomal subunits to functional 70S ribosomes.
Corresponding experiments with the translational elements of
mitochondrial ribosomes from mammalian cells (pig liver)
confirmed these results. In the presence of purified mitochondrial
factors mtEF-Tu, mtEF-Ts, mtEF-G1, poly(U) and [14C]Phe-
tRNA oligo(Phe) synthesis was severely reduced upon addition of
the mitochondrial RsfA orthologue C7orf30 (mtRsfA; Figure 4C).
The results suggest that the function of RsfA is conserved from
bacteria to eukaryotic mitochondria.
Discussion
The cellular synthesis machinery runs at high speed in the
exponential (logarithmic) phase of bacterial growth. The growth
rate slows in semi-log phase and finally comes to a halt at higher
cell density in the stationary phase, usually caused by nutrient
depletion. Several bacterial factors bind to ribosomes and thus
support the dormant state of the ribosomes in the stationary phase,
such as the ribosome modulation factor (RMF), hibernation
promoting factor (HPF) or stationary-phase-induced ribosome-
associated protein (SRA) [18,19,20,21]. RMF (homologues exist
only in the c-proteobacteria) alone or together with the more
broadly distributed HPF are essential for the formation of 70S
dimers in the stationary phase, so called 100S particles; an
inactivation of the RMF gene causes a viability defect at prolonged
RsfA Is a Ribosomal Silencing Factor
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periods in stationary phase [22,23]. Phenotypical effects of knock-
out strains concerning the other factors have not been reported.
A first analysis of RsfA-binding partners identified a group of
proteins including a number of ribosomal proteins [6]. Similarly,
other groups suggested various ribosomal proteins as binding
partners [3,4,5], the common denominator being that all proteins
were derived from the large subunit. Thorough analyses presented
here identified the ribosomal protein L14 as the docking station
(Figure 1B–1G, Figure 2), and mutation of conserved amino acid
residues of L14 at the surface of this protein abolished RsfA binding,
clearly demonstrating L14 as the binding protein (Figure 2).
Interestingly, the three most conserved residues of RsfA as shown by
the multiple sequence alignment (Figure S1A) are located at the
interface with L14 predicted by docking. The three residues are
W120, D124 and R140 (alignment numbers), corresponding to
residue numbers W77, D81 and R95 in E. coli RsfA. D81 is
predicted to be in direct contact with R98 of L14 that was shown to
disrupt the interaction when mutated. Another such critical residue,
K114 of L14, is predicted to be in contact with a fairly conserved
residue with RsfA L103 (position 148 in the alignment).
The only other known protein that like RsfA also docks to the
ribosomal protein L14 of eukaryotic ribosomes is the so-called
initiation factor eIF6, which is not a homologue to RsfA and is
thought to block ribosome association in archaea and in
eukaryotes from yeast to man [24,25,26,27,28,29]. However, in
eukaryotes eIF6 is rather a 60S assembly factor and plays an
essential role in the late pre-25S rRNA processing and the export
of the 60S subunit from the nucleolus to the cytoplasm [30].
Depletion of eIF6 is eventually lethal, in contrast to RsfA.
Interestingly, eIF6 is restricted to the eukaryotic nucleus/
cytoplasm and to archaea [27], while RsfA is present in almost
all bacteria and their descendent eukaryotic organelles (Figure 1A).
Studies with the human mitochondrial homologue of RsfA,
C7orf30, have recently suggested that this protein is involved in
ribosomal assembly and/or translation [5,8]. Our results do not
indicate any assembly defects as deletion strains of rsfA appear to
have perfectly assembled ribosomes (sucrose gradients not shown)
and actually translate as well as wild type strains at logarithmic
phase (Figure 3F). In addition, we could show that C7orf30
inhibits translation by mitochondrial ribosomes (Figure 4C). It
remains possible that C7orf30 has multiple roles in mitochondria
or that its role in ribosome assembly is indirect.
In rich medium bacterial cells produce proteins at maximum
rates to sustain cell division. Furthermore, bacterial cells take up
many metabolic precursors such as amino acids and thus block
corresponding synthesis pathways. In contrast, in poor/minimal
medium protein synthesis must be down-regulated in a concerted
fashion in order to save energy and resources, and at the same
time many synthesis pathways such as those for the synthesis of
amino acids have to be switched on [31,32]. The results
presented here suggest that RsfA plays a prominent role in this
down-regulation by silencing ribosome activities. We observe
two strong phenotypes with the DrsfA strain: (i) the viability is
strongly impaired in the stationary phase (Figure 3E) and (ii)
after a transition from rich to poor media the adaptation phase
lasts more than 10 hours before resuming growth again in
striking contrast to WT cells (Figure 3B), which overgrow the
mutant strain in a few generations. Just adding casamino acids to
the minimal medium relieves the strong growth defects of the
DrsfA strain (Figure 3A). Adding amino acids will switch off most
of the amino-acid synthesis pathways similar to the situation
during the logarithmic phase in the presence of rich medium,
when the silencing effect of RsfA is not strictly required. In
contrast, during starvation and in the absence of ribosomal
Figure 4. RsfA inhibits translation by blocking ribosomal
subunit joining. (A) Oligo(Phe) synthesis in a pure system containing
pre-charged Phe-tRNAs (ten times over ribosomes), 30S and 50S
subunits and the purified factors EF-Tu, EF-Ts and EF-G plus/minus RsfA
from E. coli, 100% corresponds to 7 Phe incorporated per ribosome. Left
panel, when indicated RsfA was added to the 50S subunits, before 30S
subunits were added starting oligo(Phe) synthesis. Right panel, AcPhe-
tRNA was bound to 70S ribosomes in the presence of poly(U) before the
addition of RsfA. (B) Sister-aliquots from the same samples shown in (A)
were analyzed on a sucrose gradient before oligo(Phe) synthesis. The
presence of RsfA significantly reduces the fraction of 70S ribosomes. (C)
Oligo(Phe)-synthesis as in (A) but with purified mitochondrial compo-
nents (pig liver) and human mtRsfA (C7orf30). 39S and 28S indicate the
large and small ribosomal subunits, 55S the associated mitochondrial
ribosomes. For details see Experimental Procedures.
doi:10.1371/journal.pgen.1002815.g004
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silencing (DrsfA), energy would be wasted affecting the conver-
sion of the metabolic network, eventually causing deleterious
growth defects. Accordingly, protein synthesis is seriously
attenuated in the stationary phase, when RsfA is present (i.e.
wild type cells) in contrast to protein synthesis in the DrsfA strain
(Figure 3F). Attenuation of protein synthesis by RsfA seems to be
of utmost importance for reorganization the metabolic state on
the way to the stationary phase, since the absence of this factor
threatens seriously the viability in the stationary phase
(Figure 3E), and it explains the well-known effect that ribosomes
are much less active, when derived from the stationary rather
than from log-phase cells [33].
When RsfA is added to ribosomal subunits it blocks 70S
formation and thus protein synthesis (Figure 4A and 4B), whereas
the factor does not interfere with the elongation phase of protein
synthesis when added to ribosomes that have passed the initiation
phase (Figure 4A, right panel). We conclude that RsfA, as a
ribosomal silencing factor, is damping the translational activity
under restricted energy (stationary phase) or nutrient conditions
(growth in poor medium) thus harmonizing translation with the
general metabolic state, i.e. RsfA works in line with the stringent
response [34] and thus plays a key role in the physiology of the
stationary phase and the translational adaptation during the
transition from rich to poor medium.
Our experiments suggest a direct silencing effect of RsfA
sketched in Figure 5: when the ribosomal activity should be
silenced, RsfA binds to the ribosomal protein L14 at the interface
of the large subunit and by impairing association of the ribosomal
subunits translation is hampered. We demonstrated that RsfA
damps the ribosomal elongation in bacterial and mammalian
mitochondrial systems (Figure 4A and 4C). The importance of
RsfA in eukaryotic organelles is indicated by the fact that a
mutation in the gene of the RsfA orthologue Iojap in Zea mays
leads to irregular albino patterns on maize leafs and germless seeds
due to failure of proplastids to differentiate into chloroplasts
[35,36,37,38]. Photosynthesis and respiration can vary enormously
in plastids and mitochondria, respectively, and as suggested by the
experiment shown in Figure 4C, the RsfA orthologue might
accordingly regulate protein synthesis in these organelles using the
mechanism suggested here.
Materials and Methods
Cloning
ORFs were cloned into pDONR207 by using the Gateway
Technology (Invitrogen). Zea mays cDNA was kindly provided by
F. Hochholdinger (Tu¨bingen, Germany), HeLa cDNA by O.
Kassel (Karlsruhe, Germany), S. pneumoniae TIGR4 DNA by D.
Nelson (UMBI, MD, USA), T. pallidum DNA by T. Palzkill
(Houston, USA), and Synechocystis PCC 6803 DNA by T.
Lamparter (Karlsruhe, Germany). All ORFs were cloned with a
stop codon at the 39-ends. Entry plasmids were sequenced,
shuttled into expression vectors (see below), and finally verified by
PCR reactions. For the interologous tests E. coli ORFs were kindly
provided as pENTR/Zeo clones by S.V. Rajagopala [39] except
for RsfA and L14 which have been cloned in this study.
E. coli L14 (b3310) alanine substitutions were directionally
introduced by performing standard fusion PCR reactions using
mutagenic primers. For cloning PrimeStar HS DNA Polymerase
was used (Takara Bio Inc.).
Yeast two-hybrid assays
Entry plasmids were recombined with the bait and prey vector
pGBKT7g and pGADT7g (Clontech) [40]. These were individ-
ually transformed into the haploid yeast strains AH109 and Y187
[41,42]. After mating the haploids and enrichment of diploids,
yeast growth was observed on solid starvation medium lacking
Leucine, Tryptophan, and Histidine. The medium contained
various concentrations of 3-AT (0 to 100 mM). Detailed proce-
dures were done as described elsewhere [43].
In case of the L14-interaction epitope mapping experiment bait
and prey plasmids were sequentially cotransformed into haploid
yeast strain CG-1945 (Clontech) and then assayed as described
above.
Pull down assays
ORFs were shuttled from entry plasmids into pNusA (Santhera,
Liestal, Switzerland), pETG-40A, or pETG-30A (EMBL, Heidel-
berg, Germany) and transformed or co-transformed into E. coli
BL21(DE3) (combinations, see main text, Figure 1D and 1E and
Figure S3A). Proteins were expressed following standard protocols.
Cell pellets were lysed in 500 ml buffer (50 mM Tris-HCL pH 8.0,
100 mM NaCl, 50 mg/ml chicken egg white lysozyme, 50 mM
PMSF, Sarcosyl/Triton-X 100 0.1%, each) and then sonicated
and centrifuged. The supernatants were used for pull-down
experiments: for E. coli RsfA and L14 corresponding volumes of
50 mg soluble protein fractions of co-expressed proteins were
applied to beads and aliquots saved as input controls. For human
and Zea mays proteins 25 mg soluble fractions were mixed and then
applied to the beads. MBP fusions were co-purified with their GST
baits on 20 ml glutathione beads and NusA-tagged preys with their
Figure 5. A model of RsfA action. In rich medium and during exponential growth, RsfA is either not present or not active, so that protein
synthesis is fully active. In starving cells, RsfA binds to ribosomal L14 and, as a consequence, blocks ribosomal subunit joining and thus protein
synthesis.
doi:10.1371/journal.pgen.1002815.g005
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MBP fusions on 20 ml amylose beads under buffer conditions
indicated above but w/o lysozyme. Binding occurred at room
temperature for 30 min. Then, the beads were washed and finally
boiled in 50 ml Laemmli buffer. 10 ml of output (‘ = 10 mg protein
input) and 10 mg input samples were separated by SDS PAGE
using 12% gels. Proteins were transferred onto a polyvinylidene
fluoride membrane by semi-dry Western blotting. The recombi-
nant bait and prey proteins were labeled by standard immuno-
detection procedure and then analyzed by enhanced chemilumi-
nescence.
In vivo localization and BiFC assays
Human C7orf30 (mtRsfA) and L14mt full-length ORFs were
cloned into pcDNA3.1-HA-mCherry [44], pcDNA3.1(+)-HA-VN,
and pcDNA3.1(+)-HA-VC [45] (Note: an N-terminal HA tag from
the vector backbones was removed under consideration that the
native mitochondrial localization peptides of mtRsfA ( = C7orf30)
and L14mt are N-terminally exposed).
For localization studies, Hela cells were transfected (100 ng,
each plasmid) with mCherry-tagged C7orf30 or L14mt using
Promofectin (Promokine, Germany). 100 ng pECFP-Mem (Clon-
tech) was co-transfected to stain cell membranes. 24 h later,
MitoTracker Green FM (100 nM f.c., Invitrogen) was added.
After washing, DRAQ5 (1:2,000, Biostatus) was added fur nuclear
staining.
For BiFC assays [46], Hela cells were prepared correspondingly.
Exceptions: Mitotracker staining was not done and instead of
localization constructs, cells were co-transfected with BiFC
plasmid constructs (50 ng, each) in combinations as given in
Figure 1G.
30 min post DRAQ5 administration cells were analyzed by
fluorescence microscopy using a Zeiss LSM 510 Meta confocal
laser scanning microscope.
Conservation of L14 residues
Multiple alignments were generated using ClustalW [47] with
the L14 amino acid sequences from E. coli, T. pallidum, S.
pneumoniae, Synechocystis PCC 6803, C. jejuni, H. sapiens, Zea mays,
Chromobacterium violaceum, Bacillus halodurans, and S. cerevisiae using
default parameters. Based on that alignment the conservation
scores were calculated with the ConSurf Server [48]. 3D images
(Figure 2A) were presented using PyMol 1.5 (http://pymol.org).
Protein docking
Structures of unbound proteins: the E. coli L14 structure was
taken from 2AWB PDB entry, chain K [14]. Because the crystal
structure of E.coli RsfA is not available, we used I-TASSER server
[49] to build a model of that protein. The server built a single
model using as templates 2ID1_A and 2O5A_A. The server has
estimated the accuracy of the model as 0.9060.06 (TM-score) and
1.661.4 A˚ (RMSD).
An unconstrained rigid body docking was performed of
individual L14 and RsfA structures with GRAMM-X [50]. We
then used the coordinates of L14 to superimpose 100 top scored
docking models onto the entire 70S unit (2AWB and 2AW7 PDB
IDs). Then, each model was evaluated for the backbone clashes
between the predicted RsfA position and the rest of the 50S
subunit. We defined a clash as having less than 2 A˚ distance
between backbone atoms in order to tolerate some degree of
unknown conformational re-arrangement of the 50S components
that were not used in docking. Model #17 was the first one in
order of the docking score where RsfA had no clashes with other
parts of 50S (parts not seen by the docking procedure). Model #17
contained certain surface exposed amino acid residues of L14 that
are highly conserved (Figure 2B). To test whether these are
involved in mediating the interaction with RsfA they were
subjected to alanine substitution constructs (see above and
Figure 2A) and analyzed in Y2H experiments (Figure 2C). The
interface contacts were defined as having less than 4.6 A˚ distance
between any heavy atoms of the docking subunits. We used PyMol
1.5 (http://pymol.org) for the post-docking analysis and graphics.
b-galactosidase expression in logarithmic and stationary
phase
DrsfA (b0637) [16] and wild type (BW25113) were transformed
with a b-galactosidase reporter plasmid, pBAD24-lacZ-HA
(based on pBAD24HA) [51,52] and selected on LB agar
containing 50 mg/ml ampicillin. Both were grown overnight in
LB in the presence of 50 mg/ml ampicillin and 0.4% glucose as
inhibitor of leaky expression. For stationary phase expression
cultures were centrifuged at 5,000 rpm (15 min) and pellets were
resuspended in the cell-free supernatant of an LB overnight
culture (BW25113/DrsfA, no plasmid) lacking glucose. b-galacto-
sidase expression was induced with 2% arabinose; the resuspen-
sion was adjusted to the same cell density as the previous
stationary-phase culture. For logarithmic phase expression
overnight cultures were centrifuged at 5,000 rpm for 15 min
and pellets were resuspended in fresh LB medium (no glucose)
with 50 mg/ml ampicillin for both strains. Cultures were then
diluted to OD600 = 0.05 and grown for 2 h. b-galactosidase
expression was induced by adding 2% arabinose to the medium.
The cultures were shaken at 37uC. Every hour 300 ml suspension
was withdrawn, 100 ml from it was loaded into a well of a 96-well
plate (flat bottom) and the growth was followed by monitoring the
extinction at 600 nm (ELISA spectrophotometer). The rest of
aliquots were centrifuged at 12,000 rpm for 5 min and pellets
were resuspended in 20 ml loading buffer (26) Tris-glycine SDS
and incubated at 95uC for 5 min to denature proteins. Samples
were loaded on SDS-polyacrylamide gel (10%) and the b-
galactosidase amount was quantified as relative protein-band
intensity using ImageJ 1.45.
Growth/viability competition assay
For growth competition assays (Figure 3A) the same amount of
cells from overnight cultures of wild type and DrsfA strains were
mixed, yielding a final OD600 of 0.01 in a volume of 5 ml, and
incubated with mild shaking either in LB (rich) or M9 medium
with 0.4% glucose (poor). Aliquots were withdrawn every 3 h or
6 h or 24 h (depending on the growth rate) and OD600 was
measured. Simultaneously, dilutions to approximately 5,000 cells/
ml (according to the assumption that 1 OD600 corresponds roughly
to 109 cells) were made and 100 ml of each was plated in duplicates
on either LB plates or LB plates containing 25 mg/ml kanamycin.
The number of colonies (DrsfA contained a kanR-cassette, WT not)
was counted after incubation at 37uC for overnight. For viability
competition experiment in stationary phase (LB medium;
Figure 3F) DrsfA mutant and wild type strain were separately
grown overnight. Subsequently two cultures were diluted to
OD600 = 0.005 and incubated with shaking till 0.5 OD600. Then
two cultures were mixed and the fitness of DrsfA was monitored as
numbers of colonies on LB plates (mutant and wild type colonies)
and LB plates containing kanamycin (only mutant colonies) after
2, 6, 9, 21, 32, 52, 78 hours of incubation at 37uC.
Romoval of the kanR-cassette in the DrsfA strain
The kanamycin resistance gene that substituted the rsfA was
removed by introducing a flippase-encoding plasmid pCP20 as
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described elsewhere [53]. The successful flip-out was verified by a
genotyping PCR.
Media shift rich to poor
For the media shift (Figure 3B) wild type and DrsfA strains were
grown overnight in LB medium (rich) and then diluted in either
LB (rich) or M9 medium (poor) yielding a start OD600 = 0.005.
Cultures were incubated at 37uC with shaking (200 rpm) and
growth was monitored measuring the OD600 over a time of up to
40 hours.
For curing the phenotype of the DrsfA strain during the
transition from rich to poor (Figure 3C and 3D) DrsfA cells lacking
the kanamycin resistance gene and wild type cells were
transformed with a plasmid harbouring the gene coding for RsfA
fused with a C-terminal His-tag under control of either the native
promoter or the IPTG inducible tac-promoter and with the
corresponding empty plasmid.
The transformed strains were grown overnight in rich (LB)
medium at 37uC and then diluted in poor M9 medium yielding a
start OD600 = 0.005 and incubated like described above. At several
time points samples were withdrawn and the expression of RsfA
was analysed after SDS-PAGE and Western-blot using an
antibody directed against the His-tag. The intensity of the RsfA-
His bands was quantified using ImageQuant 5.2 and normalized
for correction of the input to a non-altered protein band of the
Coomassie stained gel.
Expression and purification of E. coli RsfA and human
mtRsfA
The gene coding for E. coli RsfA (b0637) was expressed as an N-
terminal His6 tag fusion in E. coli BL21(DE3). Expression was
induced at OD600 = 0.4 with 0.1 mM IPTG and carried out for 2 h
at 30uC to decrease the formation of inclusion bodies. The soluble
protein was purified via nickel-nitrilotriacetic-acid-agarose (Qiagen,
according to the manufacturer’s manual) and anion exchange
chromatography (Source 15Q, GE Healthcare). The purified
protein was dialyzed against 20 mM Hepes, 6 mM Mg-acetate,
150 mM K-acetate, 4 mM b-mercaptoethanol, pH 7.6 at 0uC.
The gene coding for the mature human mitochondrial RsfA
(C7orf30; amino acids 23–234) was expressed and the protein
purified like the E. coli RsfA orthologue.
Both proteins were expressed using the Gateway System-
compatible plasmid pHGWA [54].
Isolation of ribosomal components
Ribosomes and ribosomal subunits were prepared from E. coli
strains CAN20-12E [55] as described [56]. Preparation of
mammalian mitochondrial ribosomes and ribosomal subunits
(pig liver) followed [57] with minor modifications. Hepes-buffer
and TCEP were utilized instead of Tris-buffer and 2-mercapto-
ethanol, respectively. Isolation of mitochondrial factors are
described in [58].
Poly(U)-dependent oligo(Phe) synthesis with precharged
Phe-tRNA and sucrose gradient analysis
18 pmol 50S ribosomes were incubated with 180 mg poly(U)
with or without 360 pmol RsfA in 90 ml for 10 min at 37uC in
binding buffer (20 mM Hepes, pH 7.6 at 0u C, 4.5 mM Mg-
acetate, 150 mM K-acetate, 4 mM b-mercaptoethanol, 2 mM
spermidine, 0.05 mM spermine, H20M4.5K150SH4Spd2Spm0.05).
Reaction was further incubated with 10 pmol 30S ribosomes for
10 min at 37uC and then analyzed in poly(U) dependent
oligo(Phe) synthesis and sucrose gradient centrifugation.
15 ml of the reaction was used for oligo(Phe) synthesis. 2.4 pmol
EF-G together with the ternary complex mix were added yielding
30 ml in binding buffer H20M4.5K150SH4Spd2Spm0.05. The
ternary complex mix contained in 15 ml 30 pmol [14C]Phe-
tRNAPhe, 45 pmol EF-Tu, 45 pmol EF-Ts, 3 mM GTP and was
preincubated 5 min at 37uC. Incubation was at 30uC for 2 min
and 12.5 ml aliquots were precipitated with TCA, incubated at
90uC in the presence of 2 drops of 1% (w/v) BSA and filtered
through glass filters and counted.
60 ml of the reaction was mixed with 40 ml
H20M4.5K150SH4Spd2Spm0.05 and loaded onto a 10–30% sucrose
gradient prepared in the same buffer. Centrifugation was carried
out at 42,000 rpm for 4 h in an SW60 rotor. The gradient was
pumped out from bottom to top and the A260 was measured to
obtain the ribosome profile.
The corresponding assay with mitochondrial components from
pig liver was performed in H20M4.5K150SH4Spd2Sp0.05 pH7.5 (at
0uC). mtRsfA was pre-incubated with 2.5 pmol large subunit 39S
in 80 molar excess over ribosomes, before the same amount of 28S
subunits were added; likewise 2.5 pmol 55S ribosomes were
incubated with the same amount of RsfA. EF-G1 was added in a
0.8-fold excess over ribosomes. 37.5 pmol of [14C]Phe-tRNA were
present and the mitochondrial factors mtEF-Tu and mtEF-Ts,
were added both in an excess of 1.5 over Phe-tRNA. The total
volume was 100 ml, the main incubation 20 min at 30uC. The
following processing was as described above.
The oligo(Phe) synthesis with reassociated 70S ribosomes
(Figure 4A, right panel) was performed in the following way:
3 pmol 70 S ribosomes were incubated with 30 mg poly(U) and
6 pmol Ac-Phe-tRNA for 10 min at 37uC. When indicated
60 pmol RsfA was added and the oligo(Phe) synthesis performed
as described above. The total volume was 20 ml, the mixture was
incubated for 5 min at 37uC.
Supporting Information
Dataset S1 PDB file of the ribosome with bound RsfA.
(ZIP)
Figure S1 Multiple sequence alignments of selected RsfA and
L14 orthologues. (A) Protein sequences of RsfA orthologues which
were shown to interact with L14, as well as orthologues from yeast
and two species with available 3D-structures (Chromobacterium
violaceum, PDB id: 2ID1 and Bacillus halodurans, PDB id: 2O5A). (B)
Multiple sequence alignment of corresponding L14 protein
sequences (only plastidal or mitochondrial L14 are shown for
Zea mays, human and yeast, respectively). Amino acid residues of E.
coli L14 that have been exchanged to alanine for interaction
epitope mapping (Figure 2B) are highlighted in red (residue is
involved in RsfA binding) and green (not involved in RsfA
binding). Numbers on the left and right of the alignment sequences
indicate the alignment start and stop positions, respectively.
Consensus sequences shown at the top of each alignment were
constructed with WebLogo V2.8.2 using default settings [60].
Multiple alignments were made using ClustalW2 [47]. Abbrevi-
ations: SYN (Synechocystis sp. PCC 6803), ZMA (Zea mays), TPA
(Treponema pallidum), ECO (Escherichia coli), CVI (Chromobacterium
violaceum), CJE, (Campylobacter jejuni), SPN (Streptococcus pneumoniae),
BHA (Bacillus halodurans), SCE, (Saccharomyces cerevisiae), HSA (Homo
sapiens).
(PDF)
Figure S2 Interologue tests. Pairwise Y2H interaction assays
carried out with homologous protein pairs of E. coli that have been
detected for RsfA in other studies (tested interactions and reference
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sets, see Table S1). Protein pairs were tested reciprocally (i.e., RsfA
tested as bait and prey fusion) as quadruplicates on various
concentrations of 3-AT. Baits are shown on top, preys are below in
the legends. ‘‘C’’, negative control: bait constructs are tested
against the prey vector that does not contain any insert to check
for reporter gene self-activation of the bait. Only the E. coli
interaction of RsfA with L14 turned out to be conserved.
(PDF)
Figure S3 Interaction of RsfA-L14 in E. coli, S. pneumoniae, and
Synechocystis. (A) Verification of E. coli RsfA-L14 interaction by a
pull down assay. RsfA was tagged with glutathione S-transferase
‘‘G’’ and L14 with maltose binding protein ‘‘M’’; i = input and
o = output samples. (B, C) RsfA and L14 of Streptococcus pneumoniae
TIGR4 (B) and Synechocystis PCC 6803 (C) interact in Y2H assays.
Protein pairs were tested in quadruplicates on various concentra-
tions of 3-AT. C, control (empty prey vector).
(PDF)
Table S1 RsfA and L14 and their interaction are conserved in
bacteria and eukaryotic organelles. (A) Known interactions of
RsfA with L14 orthologues and physical association with the LRS.
The table summarizes all known binary interactions among RsfA-
L14 orthologous pairs as well as co-purified ribosomal protein
complexes from this and other studies. RsfA-L14 interactions
identified by binary methods are highlighted in light grey. RsfA
orthologues co-purified with protein complexes/the ribosome are
highlighted in dark grey. Abbreviations used: LRS (large
ribosomal subunit), Y2H (yeast-2-hybrid), MS (mass spectrometry),
Co-IP (co-immunoprecipitation), BiFC (bimolecular fluorescence
complementation).
(DOC)
Table S2 RsfA interactions tested negatively with E. coli
homologous protein pairs in a Y2H experiment (see Supplemen-
tary Figure S2). Orthologues from T. pallidum and C. jejuni were
selected by MBGD orthologous protein groups [61]. The
reference set gives the source of RsfA orthologous interactions
they were primarily described in. Note, the interaction partners
identified by Butland et al. are proteins that have been co-purified
as protein complex of E. coli RsfA.
(DOC)
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